2022
DOI: 10.1155/2022/7468453
|View full text |Cite
|
Sign up to set email alerts
|

Do Antinuclear Antibodies Influence the Clinical Features of Chronic Spontaneous Urticaria?: A Retrospective Cohort Study

Abstract: Background. Antinuclear antibody (ANA) is often used as a screening test for autoimmune comorbidities in patients with chronic spontaneous urticaria (CSU). However, the relationship of ANA status and the clinical course of the disease have not been fully described. Objectives. To compare clinical features of CSU patients who are positive and negative for ANA. Methods. This was a retrospective cohort study that enrolled CSU patients attending the Urticaria Clinic at Siriraj Hospital from 2013 to 2019. Demograph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 31 publications
0
0
0
Order By: Relevance
“…There has been no previous study regarding allergic rhinitis and DFS positivity, and a low rate of ANA positivity in allergic rhinitis was reported [14]. The relation between atopic dermatitis with DFS negativity observed in this study is contrary to that reported in other reports [5,13].…”
Section: Discussioncontrasting
confidence: 99%
“…There has been no previous study regarding allergic rhinitis and DFS positivity, and a low rate of ANA positivity in allergic rhinitis was reported [14]. The relation between atopic dermatitis with DFS negativity observed in this study is contrary to that reported in other reports [5,13].…”
Section: Discussioncontrasting
confidence: 99%
“…Additional tests, including extensive food/inhalant allergy testing, are rarely needed and should only be performed if indicated by the patient’s history and physical examination [ 1 , 5 ]. Although there is no specific guideline-based recommendation to routinely test for antinuclear antibodies (ANA), individual patient factors and clinical judgement can influence the decision to test for ANA or other autoimmune markers [ 53 ].…”
Section: Diagnosis and Managementmentioning
confidence: 99%